Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Stoughton, MA
SEC filing record 1 source field available
Fiscal year end
31 December
COLLEGIUM PHARMACEUTICAL, INC has filed 862 SEC EDGAR filings since 20 Oct 2003

SEC filing history

Showing 151-175 of 856 matching filings.

Per page
25
Current page
7
144 File 001-37372

144 filing

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37372

144 filing

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37372

144 filing

Filing date
05 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37372

144 filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88843

SCHEDULE 13G filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88843

SCHEDULE 13G filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
05 Feb 2025
Reporting date
04 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
05 Feb 2025
Reporting date
04 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37372

144 filing

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
14 Nov 2024
Reporting date
12 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
14 Nov 2024
Reporting date
12 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-37372

FORM 8-K/A

Filing date
14 Nov 2024
Reporting date
03 Sep 2024
Next action
Verify source filing
SC 13G File 005-88843

PRINCIPAL GLOBAL INVESTORS

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88843

SC 13G/A

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .